Cleared Traditional

K213969 - VisionAir Patient-Specific Airway Stent (FDA 510(k) Clearance)

Oct 2022
Decision
291d
Days
Class 2
Risk

K213969 is an FDA 510(k) clearance for the VisionAir Patient-Specific Airway Stent. This device is classified as a Prosthesis, Tracheal, Preformed/molded (Class II - Special Controls, product code NWA).

Submitted by New Cos Inc. Dba Visionair Solutions (Cleveland, US). The FDA issued a Cleared decision on October 7, 2022, 291 days after receiving the submission on December 20, 2021.

This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 878.3720. The Device Is Intended To Provide Support To Weakened Or Constricting Airway Walls..

Submission Details

510(k) Number K213969 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 20, 2021
Decision Date October 07, 2022
Days to Decision 291 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF

Device Classification

Product Code NWA - Prosthesis, Tracheal, Preformed/molded
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.3720
Definition The Device Is Intended To Provide Support To Weakened Or Constricting Airway Walls.